Akebia Therapeutics' IPO

Akebia Therapeutics raised a round of funding on March 21, 2014. Investors include Public.

Akebia Therapeutics is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease. The company's lead compound, AKB-6548, is a once dail…

Articles about Akebia Therapeutics' IPO: